“Global Hypertension Drugs market set to grow to $23bn by 2024” says Visiongain report

31 July 2019
Pharma

Visiongain has launched a new pharma report Global Hypertension Drugs Market 2019-2029: Angiotensin II Receptor Blockers (ARBs), Angiotensin-converting Enzyme (ACE) Inhibitors, Beta Blockers, Calcium Channel Blockers (CCBs), Diuretics, Fixed-dose Combinations (FDCs).

Rising geriatric population and growing government initiatives to curb hypertension and its complications has boosted the growth of hypertension drugs market however, lack of new drugs in the market to treat hypertension coupled with cutthroat competition among the generic drug manufacturers have led to negative growth of this market.

The lead analyst of the report commented "Approximately, 10-15% of hypertension patients are resistant to current treatment options, where blood pressure is uncontrolled with three or more different classes of hypertension drugs, including a diuretic. Therefore, the need for new treatment strategies to treat the multi-faceted nature of hypertension, including organ protection, is still an area of intensive research."

Leading companies featured in the report include Actelion (now J&J), AstraZeneca, Boehringer Ingelheim GmbH, Daiichi Sankyo, Johnson & Johnson Company. Merck & Co. and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

The Global Wound Care Market Is Set to Boom, Particularly in Emerging Economies

The global wound care market is big, and only set to grow bigger.  Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024.  The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …

30 March 2020

Read

“The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report

Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.

30 March 2020

Read

“Global Stem Cell Technologies and Applications market set to grow to $10903.0m by 2025” says new Visiongain report

New technologies will be needed to ensure that scaling-up of manufacturing operations can be done effectively once stem cell treatments enter the market.

24 March 2020

Read

Visiongain publishes Novel Coronavirus (COVID-19) Drugs in Development Market Forecast 2020-2030 report

As per the latest reports of UNCTAD (United Nations Conference on Trade and Development), COVID-19 pandemic has not only led to tragic human consequences but is projected to cost the global economy $1 trillion in 2020.

24 March 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever